Efficacy of lenalidomide for relapsed or refractory T lymphoblastic lymphoma/leukemia after allogeneic hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Efficacy of lenalidomide for relapsed or refractory T lymphoblastic lymphoma/leukemia after allogeneic hematopoietic stem cell transplantation

Published:2021-05-17 Issue: Volume: Page:1-5
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Liang Dan¹^ORCID,Wei Cong¹,Zhang Xiaoting¹,Yang Jilong¹,Zheng Yaling¹,Du Jingwen¹,Wang Liang²³^ORCID,Deng Lan¹⁴^ORCID

Affiliation:

1. Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China

2. Department of Hematology, Beijing TongRen Hospital, Capital Medical University, Beijing, China

3. Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University & Capital Medical University, Beijing TongRen Hospital, Beijing, China

4. Department of Hematology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.1919665

Reference13 articles.

1. Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment

2. Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic Leukemia

3. A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid®) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: The EXPECT trial

4. A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma

5. Final report of a phase 2 clinical trial of lenalidomide monotherapy for patients with T-cell lymphoma

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lenalidomide Treatment of Isolated Central Nervous System Relapse in Acute Lymphoblastic Leukemia after Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy;Acta Haematologica;2024-02-15

2. Stem Cell Therapy for HTLV-1 Induced Adult T-Cell Leukemia/Lymphoma (ATLL): A Comprehensive Review;Pathology - Research and Practice;2024-01

3. Role of allogeneic hematopoietic stem cell transplantation in patients with high-risk T-cell lymphoblastic leukaemia/lymphoma: an analysis of clinical outcomes;Bone Marrow Transplantation;2023-12-23

4. PET/CT Evaluation of the Effect of Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of T-Cell Lymphoblastic Lymphoma;Contrast Media & Molecular Imaging;2022-08-16